Koppert P W, Huijsmans C M, Nieuwenhuizen W
Blood. 1985 Sep;66(3):503-7.
Spleen cells of BALB/c mice, immunized with fragments Y of normal human fibrinogen, were fused with P3 X 63 Ag 8653 myeloma cells. A clone was found which produces monoclonal antibodies (Mab-Y18) of the IgM kappa type. Mab-Y18 is immunoreactive with normal human fibrinogen, and its fragments X, Y, N-terminal disulphide knot, A alpha-chain, and A alpha stretch 1-51. The immunoreactivity with these same fragments disappears upon treatment with thrombin or arvin. This strongly suggests that fibrinopeptide A is an essential component of the Mab-Y18 epitope. This is supported by the finding that Mab-Y18 prolongs the thrombin and arvin clotting times of human fibrinogen by inhibition of the fibrinopeptide A release. More detailed information about the nature of the Mab-Y18 epitope was obtained from studies with genetic variants of human fibrinogen (especially fibrinogen Metz) and with fibrinogens from other mammalian species. These studies show that amino acid residue A alpha 16 (arginine) of fibrinopeptide A is essential for the Mab-Y18 epitope. Mab-Y18 does not react with free fibrinopeptide A.
用正常人纤维蛋白原的Y片段免疫的BALB/c小鼠脾细胞与P3X63Ag8653骨髓瘤细胞融合。发现一个克隆产生IgMκ型单克隆抗体(Mab-Y18)。Mab-Y18与正常人纤维蛋白原及其片段X、Y、N端二硫键结、Aα链和Aα伸展区1-51具有免疫反应性。用凝血酶或蛇毒处理后,与这些相同片段的免疫反应性消失。这强烈表明纤维蛋白肽A是Mab-Y18表位的重要组成部分。Mab-Y18通过抑制纤维蛋白肽A的释放延长人纤维蛋白原的凝血酶和蛇毒凝血时间,这一发现支持了上述观点。通过对人纤维蛋白原的遗传变体(特别是纤维蛋白原梅茨)和其他哺乳动物物种的纤维蛋白原的研究,获得了关于Mab-Y18表位性质的更详细信息。这些研究表明,纤维蛋白肽A的氨基酸残基Aα16(精氨酸)对Mab-Y18表位至关重要。Mab-Y18不与游离纤维蛋白肽A反应。